Leptin treatment of patients with anorexia nervosa? the urgent need for initiation of clinical studies

European Child and Adolescent Psychiatry

Volumn 21, Issue 2, 2012, Pages 63-66

  Hebebrand, Johannes ^a   Özgür , Albayrak ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; METRELEPTIN; OLANZAPINE; RECOMBINANT LEPTIN;

ANOREXIA NERVOSA; CLINICAL TRIAL (TOPIC); DEPRESSION; FEEDING BEHAVIOR; HEALTH CARE COST; HUMAN; HYPERACTIVITY; INJECTION SITE REACTION; LIPODYSTROPHY; NAUSEA; NONHUMAN; OBESITY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STARVATION; WEIGHT REDUCTION; EDITORIAL;

ANOREXIA NERVOSA; HUMANS; LEPTIN;

EID: 84861719455     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-012-0243-3     Document Type: Review

References (24)

1. Hebebrand J, Casper R, Treasure J, Schweiger U (2004) The need to revise the diagnostic criteria for anorexia nervosa. J Neural Transm 111 (7):827-840 (Pubitemid 38916278)
2. Hebebrand J, Bulik CM (2011) Critical appraisal of the provisional DSM-5 criteria for anorexia nervosa and an alternative proposal. Int J Eat Disord 44 (8):665-678
3. Herpertz-Dahlmann B, Hebebrand J (2011) Assessment and treatment of eating disorders and obesity. In: Martin A, Scahill L, Charney DS, Leckman JF (eds) Pediatric psychopharmacology: principles and practice, Oxford, New York, pp 570-584
4. Carter FA, Jordan J, McIntosh VV, Luty SE, McKenzie JM, Frampton CM, Bulik CM, Joyce PR (2011) The long-term efficacy of three psychotherapies for anorexia nervosa: a randomized, controlled trial. Int J Eat Disord 44 (7):647-654
5. Krauth C, Buser K, Vogel H (2004) Die gesellschaftlichen Kosten von Essstörungen-Krankheitskostenanalysen für Anorexia und Bulimia nervosa. In: Vogel H, Wasem J (eds) Gesundheitsökonomie in Psychotherapie und Psychiatrie. Schattauer, Stuttgart, pp 153-173
6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372 (6505):425-432 (Pubitemid 24365442)
7. Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763-770 (Pubitemid 28485436)
8. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW (2006) Central nervous system control of food intake and body weight. Nature 443:289-295 (Pubitemid 44435142)
9. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos- Flier E, Flier JS (1996) Role of leptin in the neuroendocrine response to fasting. Nature 382 (6588):250-252 (Pubitemid 26251358)
10. Hebebrand J, van der Heyden J, Devos R, Köpp W, Herpertz S, Remschmidt H, Herzog W (1995) Plasma concentrations of obese protein in anorexia nervosa. Lancet 346 (8990):1624-1625 (Pubitemid 26002165)
11. Hebebrand J, Muller TD, Holtkamp K, Herpertz-Dahlmann B (2007) The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry 12:23-35 (Pubitemid 44973660)
12. Föcker M, Timmesfeld N, Scherag S, B ühren K, Langkamp M, Dempfle A, Sheridan EM, de Zwaan M, Fleischhaker C, Herzog W, Egberts K, Zipfel S, Herpertz-Dahlmann B, Hebebrand J (2011) Screening for anorexia nervosa via measurement of serum leptin levels. J Neural Transm 118 (4): 571-578
13. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A, Mantzoros CS (2004) Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 351 (10): 987-997 (Pubitemid 39166262)
14. Chou SH, Chamberland JP, Liu X, Matarese G, Gao C, Stefanakis R, Brinkoetter MT, Gong H, Arampatzi K, Mantzoros CS (2011) Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci USA 108 (16):6585-6590
15. Exner C, Hebebrand J, Remschmidt H, Wewetzer C, Ziegler A, Herpertz S, Schweiger U, Blum WF, Preibisch G, Heldmaier G, Klingenspor M (2000) Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa. Mol Psychiatry 5 (5):476-481
16. Hebebrand J, Exner C, Hebebrand K, Holtkamp C, Casper RC, Remschmidt H, Herpertz-Dahlmann B, Klingenspor M (2003) Hyperactivity in patients with anorexia nervosa and in semistarved rats: evidence for a pivotal role of hypoleptinemia. Physiol Behav 79 (1):25-37 (Pubitemid 36734826)
17. Holtkamp K, Herpertz-Dahlmann B, Hebebrand K, Mika C, Kratzsch J, Hebebrand J (2006) Physical activity and restlessness correlate with leptin levels in patients with adolescent anorexia nervosa. Biol Psychiatry 60 (3):311-313 (Pubitemid 44093436)
18. Yamada N, Katsuura G, Ochi Y, Ebihara K, Kusakabe T, Hosoda K, Nakao K (2011) Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 152 (7):2634-2643
19. Farooqi IS, Jebb SA, Langmack G et al (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879-884 (Pubitemid 29427050)
20. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282 (16):1568-1575 (Pubitemid 29504050)
21. Hukshorn CJ, Saris WH, Westerterp-Plantenga M et al (2000) Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J Clin Endocrinol Metab 85:4003-4009 (Pubitemid 32055343)
22. Garg A (2004) Acquired and inherited lipodystrophies. N Engl J Med 350:1220-1234 (Pubitemid 38339366)
23. Chan JL, Lutz K, Cochran E, Huang W, Peters Y, Weyer C, Gorden P (2011) Clinical effects of long-term metreleptin treatment in patients with lipodystrophy. Endocr Pract 8:1-31
24. Tam CS, Lecoultre V, Ravussin E (2011) Novel strategy for the use of leptin for obesity therapy. Expert Opin Biol Ther 11 (12): 1677-1685